By Greg Ryan ( June 28, 2012, 8:33 PM EDT) -- A U.S. Food and Drug Administration advisory panel recommended Thursday that the labeling for metal-on-metal hip implants, the target of multiple recalls and massive litigation, include warnings for tumor-like growths and elevated metal ion levels in the bloodstream....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.